{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:17:54Z","timestamp":1787761074957,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Covidien Private Limited"},{"name":"Investigator Sponsored Research Program","award":["ISR-2017-10924"],"award-info":[{"award-number":["ISR-2017-10924"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1245\/s10434-025-18573-2","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:40:48Z","timestamp":1760708448000},"page":"1350-1359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Minimally Invasive Gastrectomy for Borrmann Type IV Gastric Cancer: An Oncologically Sound Alternative to Open Surgery"],"prefix":"10.1245","volume":"33","author":[{"given":"Jawon","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minah","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung-Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8593-9214","authenticated-orcid":false,"given":"Woo Jin","family":"Hyung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"18573_CR1","doi-asserted-by":"crossref","unstructured":"Japanese Gastric Cancer A. Japanese classification of gastric carcinoma, 2nd English edition. Gastric Cancer. 1998;1:10\u201324.","DOI":"10.1007\/PL00011681"},{"key":"18573_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10120-011-0063-z","volume":"15","author":"C Pedrazzani","year":"2012","unstructured":"Pedrazzani C, Marrelli D, Pacelli F, et al. Gastric linitis plastica: which role for surgical resection? Gastric Cancer. 2012;15:56\u201360.","journal-title":"Gastric Cancer."},{"key":"18573_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.amjsurg.2004.06.010","volume":"188","author":"E Otsuji","year":"2004","unstructured":"Otsuji E, Kuriu Y, Okamoto K, et al. Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach. Am J Surg. 2004;188:327\u201332.","journal-title":"Am J Surg."},{"key":"18573_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1590\/S0100-69912011000400007","volume":"38","author":"AC Accetta","year":"2011","unstructured":"Accetta AC, Manso JE, Mello EL, Paiva RK, Castro Ldos S, Accetta P. Type IV Borrmann gastric adenocarcinoma: analysis of curative resection results. Rev Col Bras Cir. 2011;38:237\u201344.","journal-title":"Rev Col Bras Cir."},{"key":"18573_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12032-016-0783-3","volume":"33","author":"EY Kim","year":"2016","unstructured":"Kim EY, Yoo HM, Song KY, Park CH. Limited significance of curative surgery in Borrmann type IV gastric cancer. Med Oncol. 2016;33:69.","journal-title":"Med Oncol."},{"key":"18573_CR6","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/SLA.0000000000002768","volume":"269","author":"T Kinoshita","year":"2019","unstructured":"Kinoshita T, Uyama I, Terashima M, et al. Long-term outcomes of laparoscopic versus open surgery for clinical stage II\/III gastric cancer: a multicenter cohort study in Japan (LOC-A study). Ann Surg. 2019;269:887\u201394.","journal-title":"Ann Surg."},{"key":"18573_CR7","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s00464-013-3236-5","volume":"28","author":"T Son","year":"2014","unstructured":"Son T, Hyung WJ, Lee JH, Kim YM, Noh SH. Minimally invasive surgery for serosa-positive gastric cancer (pT4a) in patients with preoperative diagnosis of cancer without serosal invasion. Surg Endosc. 2014;28:866\u201374.","journal-title":"Surg Endosc."},{"key":"18573_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12957-024-03422-5","volume":"22","author":"H Pang","year":"2024","unstructured":"Pang H, Yan M, Zhao Z, et al. Laparoscopic versus open gastrectomy for nonmetastatic T4a gastric cancer: a meta-analysis of reconstructed individual participant data from propensity score-matched studies. World J Surg Oncol. 2024;22:143.","journal-title":"World J Surg Oncol."},{"key":"18573_CR9","first-page":"2243","volume":"13","author":"EM Muttillo","year":"2023","unstructured":"Muttillo EM, La Franca A, Stefanelli S, et al. Oncological adequacy of laparoscopic surgery for bulky gastric cancer: results of a Western single-center series. Life (Basel). 2023;13:2243.","journal-title":"Life (Basel)."},{"key":"18573_CR10","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s13304-024-01910-7","volume":"76","author":"VD Long","year":"2024","unstructured":"Long VD, Nguyen DT, Thong DQ, et al. Laparoscopic versus open total gastrectomy for T4a gastric cancer: a propensity score-matched analysis of long-term outcomes. Updates Surg. 2024;76:1843\u201354.","journal-title":"Updates Surg."},{"key":"18573_CR11","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.ejso.2022.05.019","volume":"48","author":"SA Jeong","year":"2022","unstructured":"Jeong SA, Yoo MW, Lee IS, et al. Comparing surgical and oncologic outcomes between laparoscopic gastrectomy and open gastrectomy in advanced gastric cancer with serosal invasion: a retrospective study with propensity score matching. Eur J Surg Oncol. 2022;48:1988\u201393.","journal-title":"Eur J Surg Oncol."},{"key":"18573_CR12","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1200\/JCO.20.01210","volume":"38","author":"WJ Hyung","year":"2020","unstructured":"Hyung WJ, Yang HK, Park YK, et al. Long-Term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: the KLASS-02-RCT randomized clinical trial. J Clin Oncol. 2020;38:3304\u201313.","journal-title":"J Clin Oncol."},{"key":"18573_CR13","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.jamcollsurg.2008.04.027","volume":"207","author":"WJ Hyung","year":"2008","unstructured":"Hyung WJ, Lim JS, Song J, Choi SH, Noh SH. Laparoscopic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer. J Am Coll Surg. 2008;207:e6-11.","journal-title":"J Am Coll Surg."},{"key":"18573_CR14","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1007\/s00464-014-3511-0","volume":"28","author":"T Son","year":"2014","unstructured":"Son T, Lee JH, Kim YM, Kim HI, Noh SH, Hyung WJ. Robotic spleen-preserving total gastrectomy for gastric cancer: comparison with conventional laparoscopic procedure. Surg Endosc. 2014;28:2606\u201315.","journal-title":"Surg Endosc."},{"key":"18573_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ejso.2006.11.010","volume":"33","author":"WJ Hyung","year":"2007","unstructured":"Hyung WJ, Song C, Cheong JH, Choi SH, Noh SH. Factors influencing operation time of laparoscopy-assisted distal subtotal gastrectomy: analysis of consecutive 100 initial cases. Eur J Surg Oncol. 2007;33:314\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"18573_CR16","doi-asserted-by":"crossref","unstructured":"Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer. 2023;26:1\u201325.","DOI":"10.1007\/s10120-022-01331-8"},{"key":"18573_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3349\/ymj.2019.60.3.235","volume":"60","author":"YY Choi","year":"2019","unstructured":"Choi YY, Cho M, Kwon IG, et al. Ten thousand consecutive gastrectomies for gastric cancer: perspectives of a master surgeon. Yonsei Med J. 2019;60:235\u201342.","journal-title":"Yonsei Med J."},{"key":"18573_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"Y-J Bang","year":"2012","unstructured":"Bang Y-J, Kim Y-W, Yang H-K, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315\u201321.","journal-title":"Lancet."},{"key":"18573_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","volume":"17","author":"M Schemper","year":"1996","unstructured":"Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17:343\u20136.","journal-title":"Control Clin Trials."},{"key":"18573_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/bjc.1995.364","volume":"72","author":"DG Altman","year":"1995","unstructured":"Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer. 1995;72:511\u20138.","journal-title":"Br J Cancer."},{"key":"18573_CR21","first-page":"897","volume":"35","author":"K Yamashita","year":"2015","unstructured":"Yamashita K, Hosoda K, Katada N, et al. Survival outcome of Borrmann type IV gastric cancer potentially improved by multimodality treatment. Anticancer Res. 2015;35:897\u2013906.","journal-title":"Anticancer Res."},{"key":"18573_CR22","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/SLA.0000000000003217","volume":"270","author":"HJ Lee","year":"2019","unstructured":"Lee HJ, Hyung WJ, Yang HK, et al. Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal gastrectomy with D2 lymphadenectomy to open distal gastrectomy for locally advanced gastric cancer (KLASS-02-RCT). Ann Surg. 2019;270:983\u201391.","journal-title":"Ann Surg."},{"key":"18573_CR23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/SLA.0b013e31824682f4","volume":"255","author":"EF Vinuela","year":"2012","unstructured":"Vinuela EF, Gonen M, Brennan MF, Coit DG, Strong VE. Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg. 2012;255:446\u201356.","journal-title":"Ann Surg."},{"key":"18573_CR24","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1200\/JCO.2015.63.7215","volume":"34","author":"Y Hu","year":"2016","unstructured":"Hu Y, Huang C, Sun Y, et al. Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial. J Clin Oncol. 2016;34:1350\u20137.","journal-title":"J Clin Oncol."},{"key":"18573_CR25","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1007\/s00268-015-3160-z","volume":"39","author":"N Inaki","year":"2015","unstructured":"Inaki N, Etoh T, Ohyama T, et al. A multi-institutional, prospective, phase II feasibility study of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for locally advanced gastric cancer (JLSSG0901). World J Surg. 2015;39:2734\u201341.","journal-title":"World J Surg."},{"key":"18573_CR26","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1007\/s10120-019-00941-z","volume":"22","author":"M Terashima","year":"2019","unstructured":"Terashima M, Iwasaki Y, Mizusawa J, et al. Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501). Gastr Cancer. 2019;22:1044\u201352.","journal-title":"Gastr Cancer."},{"key":"18573_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10120-008-0496-1","volume":"12","author":"T Kinoshita","year":"2009","unstructured":"Kinoshita T, Sasako M, Sano T, et al. Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002). Gastric Cancer. 2009;12:37\u201342.","journal-title":"Gastric Cancer."},{"key":"18573_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17588359241241972","volume":"16","author":"CH Maeng","year":"2024","unstructured":"Maeng CH, Kim H, Kim M. Time interval between surgery and adjuvant chemotherapy in patients with gastric cancer after gastrectomy: a population-based cohort study using a nationwide claim database. Ther Adv Med Oncol. 2024;16:1\u201312.","journal-title":"Ther Adv Med Oncol."},{"key":"18573_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.14216\/kjco.21005","volume":"17","author":"GY Jin","year":"2021","unstructured":"Jin GY, Park KB, Song KY. Factors related to compliance with adjuvant chemotherapy in patients with gastric cancer: a retrospective single-center study. Korean J Clin Oncol. 2021;17:31\u20136.","journal-title":"Korean J Clin Oncol."},{"key":"18573_CR30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1245\/s10434-014-3949-2","volume":"22","author":"HS Park","year":"2015","unstructured":"Park HS, Jung M, Kim HS, et al. Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer. Ann Surg Oncol. 2015;22:224\u201331.","journal-title":"Ann Surg Oncol."},{"key":"18573_CR31","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1007\/s00464-021-08430-0","volume":"36","author":"Z-N Huang","year":"2022","unstructured":"Huang Z-N, Ma Y, Chen Q-Y, et al. Potential survival benefits of open over laparoscopic radical gastrectomy for gastric cancer patients beyond three years after surgery: result from multicenter in-depth analysis based on propensity matching. Surg Endosc. 2022;36:1456\u201365.","journal-title":"Surg Endosc."},{"key":"18573_CR32","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ejso.2017.02.016","volume":"43","author":"M Sasako","year":"2017","unstructured":"Sasako M. Is there role for laparoscopic gastrectomy for advanced gastric cancer. Eur J Surg Oncol. 2017;43:965\u20137.","journal-title":"Eur J Surg Oncol."},{"key":"18573_CR33","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1001\/jamasurg.2018.4267","volume":"154","author":"IG Kwon","year":"2019","unstructured":"Kwon IG, Son T, Kim HI, Hyung WJ. Fluorescent lymphography-guided lymphadenectomy during robotic radical gastrectomy for gastric cancer. JAMA Surg. 2019;154:150\u20138.","journal-title":"JAMA Surg."},{"key":"18573_CR34","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1007\/s00464-024-10857-0","volume":"38","author":"E Akimoto","year":"2024","unstructured":"Akimoto E, Kinoshita T, Yura M, et al. Feasibility of laparoscopic\/robot-assisted surgery for Borrmann type 4 gastric cancer: a comparison study with conventional open surgery. Surg Endosc. 2024;38:3337\u201345.","journal-title":"Surg Endosc."},{"key":"18573_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/AS9.0000000000000063","volume":"2","author":"Y Fujita","year":"2021","unstructured":"Fujita Y, Nishigori T, Kadokawa Y, et al. Comparative outcomes of laparoscopic gastrectomy and open gastrectomy for scirrhous gastric cancer: a multicenter retrospective cohort study. Ann Surg Open. 2021;2:e063.","journal-title":"Ann Surg Open."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18573-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18573-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18573-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:33:40Z","timestamp":1767573220000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18573-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["18573"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18573-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.J. Hyung reports receiving research grants from Medtronic and GC Biopharma and is a stockholder and chief executive officer of Hutom. He has provided consultancy services to Ethicon and SK Hynix (Wuxi) outside the submitted work. The other authors have no disclosures to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}